UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $37,278,000 | -5.1% | 789,297 | 0.0% | 70.39% | +16.5% |
| Q2 2018 | $39,275,000 | -27.9% | 789,297 | -28.0% | 60.44% | -3.5% |
| Q1 2018 | $54,461,000 | +33.5% | 1,096,024 | 0.0% | 62.61% | +15.6% |
| Q4 2017 | $40,783,000 | -10.8% | 1,096,024 | -24.4% | 54.17% | +18.3% |
| Q3 2017 | $45,696,000 | +74.3% | 1,449,745 | -0.1% | 45.77% | +36.6% |
| Q2 2017 | $26,211,000 | – | 1,451,329 | – | 33.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |